Exhibit 99
USANA Health Sciences Announces Third Quarter 2007 Financial Results
-- Earnings Per Share Increased 25.0%, Year-over-Year, to $0.70 --
-- Net Sales Increased 15.5%, Year-over-Year, to $106.2 Million --
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 16, 2007--USANA Health
Sciences, Inc. (NASDAQ: USNA) today announced financial results for
the fiscal third quarter ending September 29, 2007.
Financial Performance
Net sales in the third quarter of 2007 increased by 15.5% to
$106.2 million, compared with $92.0 million in the third quarter of
the prior year. Net sales growth for the third quarter of 2007
resulted primarily from a 24.1% net increase in the number of active
Associates, meaning those who have purchased products directly from
the Company in the preceding three months, either for personal
consumption or for resale. Foreign currency fluctuations accounted for
3.4 percentage points of the year-over-year increase in net sales for
the third quarter of 2007.
Earnings from continuing operations in the third quarter of 2007
grew by 7.5% to $17.3 million, or 16.3% of net sales, compared with
$16.1 million, or 17.5% of net sales, in the third quarter of the
prior year. Earnings per share from continuing operations increased by
25.0% in the third quarter of 2007 to $0.70 per share, compared with
$0.56 per share in the third quarter of the prior year. This increase
was in part due to aggressive stock repurchases and a lower than
expected effective tax rate of 31.4%, offsetting higher Selling
General and Administrative expenses.
For the nine-month period ended September 29, 2007, consolidated
net sales were $314.4 million, an increase of 17.7%, compared with
$267.0 million in the first nine months of 2006. Earnings per share
from continuing operations increased 22.7% in the first nine months of
2007 to $2.00, compared with $1.63 in the first nine months of 2006.
During the third quarter of 2007, the Company repurchased 180
thousand shares for an investment of $6.6 million. During the first
nine months of 2007, the Company repurchased approximately 1.9 million
shares for an investment of about $80 million. As of the end of the
third quarter, there was about $50 million remaining under the current
stock buyback authorization.
Regional Results
During the third quarter of 2007, net sales in North America, the
Company's most mature region, increased by 10.1% to $66.6 million,
compared with the third quarter of the prior year. This growth was
driven primarily by a 16.7% net improvement in the number of active
Associates in this region to 105,000. Along with double-digit growth
in Canada, sales in Mexico increased by 19.3% over the third quarter
of last year.
"We are pleased to have achieved double-digit growth in the number
of active Associates and in net sales in the North American region,"
said Dave Wentz, the Company's President. "Both the Canadian and
Mexican markets have contributed to this region's strong sales
growth."
During the third quarter of 2007, net sales in the Asia Pacific
region increased by 25.7% to $39.6 million, compared with the third
quarter of the prior year. The growth in this region was led by
double-digit, year-over-year growth in Hong Kong and the Australia-New
Zealand markets. Malaysia continues to show steady growth as a new
market, contributing $4.9 million of incremental revenue in the third
quarter, an 8.6% increase, compared with the second quarter. The
number of active Associates in the Asia Pacific region increased by
36.4% to 75,000, compared with 55,000 in the third quarter of the
prior year. The number of Associates in our newest market, Malaysia,
grew to 12,000 in just its third quarter of operations.
"The Asia Pacific region continues to be a healthy market for
USANA," continued Wentz. "This region has been contributing an
increasing share of our growth, led by Hong Kong and Australia-New
Zealand, and we anticipate that the Malaysian market will play an
increasingly important role in this region. We continue to focus the
majority of our efforts on solidifying and growing our 13 core
markets."
Outlook
Today, the Company is providing financial guidance for the fourth
quarter of 2007 and its initial look at the full year 2008. Based on
its current business trends, the Company believes that net sales for
the fourth quarter of 2007 will be between $108 million and $110
million, a growth rate of 10% to 12%, compared with the prior year
fourth quarter. Earnings per share are expected to be between $0.66
and $0.68 for the fourth quarter of 2007. Accordingly, for the year
2007, sales are now expected to be between $422 million and $424
million, excluding revenues from our discontinued third-party contract
manufacturing business, with earnings per share between $2.66 and
$2.68. Additionally, in the Company's first look at full-year 2008, we
believe that both net sales and earnings per share will grow 10% to
13%, compared with the full-year 2007. These earnings per share
estimates assume an effective tax rate of approximately 36.0% for the
fourth quarter of 2007 and for the full-year 2008.
Gilbert A. Fuller, the Company's executive vice president and
chief financial officer, said, "Our strategy of supporting our
Associates both domestically and internationally, continues to pay off
and produce strong financial results. Going forward, we likely will
continue to buy back shares as a way of returning value to our
shareholders. We are proud to offer the finest nutritional and
personal care products in the industry."
Conference Call
USANA will hold a conference call and webcast to discuss this
announcement with investors on Wednesday, October 17, 2007 at 11:00 AM
ET. Investors may listen to the call by accessing USANA's website at
http://www.usanahealthsciences.com.
About USANA
USANA develops and manufactures high quality nutritional, personal
care, and weight management products that are sold directly to
Preferred Customers and Associates throughout the United States,
Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea,
Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom.
More information on USANA can be found at
http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of the
Securities Exchange Act. Our actual results could differ materially
from those projected in these forward-looking statements, which
involve a number of risks and uncertainties, including reliance upon
our network of independent Associates, the governmental regulation of
our products, manufacturing and marketing risks, adverse publicity
risks, and risks associated with our international expansion. The
contents of this release should be considered in conjunction with the
risk factors, warnings, and cautionary statements that are contained
in our most recent filings with the Securities and Exchange
Commission.
USANA Health Sciences, Inc.
Consolidated Statements of Earnings
(In thousands, except per share data)
Quarter Ended
-----------------------
30-Sep-06 29-Sep-07
---------- -----------
(Unaudited) (Unaudited)
Net sales $ 91,967 $106,181
Cost of sales 20,274 21,960
---------- -----------
Gross profit 71,693 84,221
Operating expenses
Associate incentives 36,994 43,021
Selling, general and administrative 17,798 23,053
Research and development 830 864
---------- -----------
Earnings from operations 16,071 17,283
Other income 65 (270)
---------- -----------
Earnings before income taxes 16,136 17,013
Income taxes 5,698 5,350
---------- -----------
Income from continuing operations 10,438 11,663
Income (Loss) from discontinued operations (215) (405)
NET EARNINGS $ 10,223 $ 11,258
========== ===========
Earnings per share - diluted
Continuing operations $ 0.56 $ 0.70
Discontinued operations $ (0.01) $ (0.02)
---------- -----------
Net Earnings $ 0.55 $ 0.68
========== ===========
Weighted average shares outstanding - diluted 18,486 16,613
========== ===========
USANA Health Sciences, Inc.
Consolidated Balance Sheets
(in thousands)
As of As of
30-Dec-06 29-Sep-07
------------ -------------
(Unaudited)
ASSETS
Current Assets
Cash and cash equivalents $ 27,029 $ 11,718
Inventories 22,483 21,058
Other current assets 11,103 12,841
------------ -------------
Total current assets 60,615 45,617
Property and equipment, net 30,323 45,838
Goodwill 5,690 5,690
Other assets 3,374 4,503
------------ -------------
Total assets $ 100,002 $ 101,648
============ =============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable $ 10,241 $ 7,910
Other current liabilities 29,564 32,507
------------ -------------
Total current liabilities 39,805 40,417
------------ -------------
Long-term liabilities
Line of Credit - 34,625
Other long-term liabilities - 1,673
Stockholders' equity 60,197 24,933
------------ -------------
Total liabilities and stockholders' equity $ 100,002 $ 101,648
============ =============
USANA Health Sciences, Inc.
Sales by Region
(in thousands)
Quarter Ended
---------------------------------
30-Sep-06 29-Sep-07
--------------- ----------------
(Unaudited) (Unaudited)
Region
-----------------------------------
North America
United States $39,425 42.9% $ 42,455 40.0%
Canada 16,574 18.0% 18,792 17.7%
Mexico 4,503 4.9% 5,372 5.1%
------- ------ -------- ------
North America Total 60,502 65.8% $ 66,619 62.8%
Asia Pacific
Australia-New Zealand 12,297 13.4% 14,163 13.3%
Hong Kong 4,582 5.0% 6,876 6.5%
Japan 2,357 2.5% 2,395 2.3%
Taiwan 5,509 6.0% 5,354 5.0%
South Korea 2,117 2.3% 1,634 1.5%
Singapore 4,603 5.0% 4,209 4.0%
Malaysia - 0.0% 4,931 4.6%
------- ------ -------- ------
Asia Pacific Total 31,465 34.2% 39,562 37.2%
------- ------ -------- ------
Consolidated $91,967 100.0% $106,181 100.0%
======= ====== ======== ======
Active Associates by Region
As of
--------------------------------
30-Sep-06 29-Sep-07
--------------- ---------------
(Unaudited) (Unaudited)
Region
------------------------------------
North America
United States 58,000 40.0% 63,000 35.0%
Canada 22,000 15.2% 28,000 15.5%
Mexico 10,000 6.9% 14,000 7.8%
------- ------ ------- ------
North America Total 90,000 62.1% 105,000 58.3%
Asia Pacific
Australia-New Zealand 18,000 12.4% 21,000 11.7%
Hong Kong 8,000 5.5% 13,000 7.2%
Japan 4,000 2.7% 5,000 2.8%
Taiwan 13,000 9.0% 14,000 7.8%
South Korea 2,000 1.4% 2,000 1.1%
Singapore 10,000 6.9% 8,000 4.4%
Malaysia - 0.0% 12,000 6.7%
------- ------ ------- ------
Asia Pacific Total 55,000 37.9% 75,000 41.7%
------- ------ ------- ------
Total 145,000 100.0% 180,000 100.0%
======= ====== ======= ======
Active Preferred Customers by Region
As of
------------------------------
30-Sep-06 29-Sep-07
-------------- --------------
(Unaudited) (Unaudited)
Region
--------------------------------------
North America
United States 49,000 64.5% 51,000 64.6%
Canada 18,000 23.7% 17,000 21.5%
Mexico 2,000 2.6% 3,000 3.8%
------ ------ ------ ------
North America Total 69,000 90.8% 71,000 89.9%
Asia Pacific
Australia-New Zealand 6,000 7.9% 6,000 7.5%
Hong Kong ** 0.0% 1,000 1.3%
Japan 1,000 1.3% 1,000 1.3%
Taiwan ** 0.0% ** 0.0%
South Korea ** 0.0% ** 0.0%
Singapore ** 0.0% ** 0.0%
Malaysia - 0.0% ** 0.0%
------ ------ ------ ------
Asia Pacific Total 7,000 9.2% 8,000 10.1%
------ ------ ------ ------
Total 76,000 100.0% 79,000 100.0%
====== ====== ====== ======
** Count of Active Preferred Customers is less than 500.
CONTACT: USANSA Health Sciences
Investor Relations:
Riley Timmer, 801-954-7922
investor.relations@us.usana.com
or
Edelman
Joe Poulos, 312-240-2719